Upregulation of transforming growth factor-β1 and vascular endothelial growth factor in cultured keloid fibroblasts: Relevance to angiogenic activity

Archives of Dermatological Research

Volumn 297, Issue 4, 2005, Pages 161-169

  Fujiwara, Masao ^a,b   Muragaki, Yasuteru ^b   Ooshima, Akira ^b  

^a TENRI HOSPITAL   (Japan)

^b WAKAYAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

Angiogenesis; In vivo model; Keloids; Transforming growth factor 1; Vascular endothelial growth factor

Indexed keywords

MESSENGER RNA; TRANSFORMING GROWTH FACTOR BETA ANTIBODY; TRANSFORMING GROWTH FACTOR BETA1; VASCULOTROPIN;

ADULT; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CHEMOTAXIS; COMPARATIVE STUDY; CONTROLLED STUDY; CULTURE MEDIUM; ELECTROIMMUNOASSAY; ENDOTHELIUM CELL; FEMALE; FIBROBLAST; HUMAN; HUMAN CELL; HUMAN TISSUE; KELOID; MALE; MOUSE; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; SCID MOUSE; STATISTICAL SIGNIFICANCE; UPREGULATION; VASCULAR ENDOTHELIUM;

ADOLESCENT; ADULT; ANIMALS; ANTIBODIES; BLOTTING, NORTHERN; CELLS, CULTURED; ENDOTHELIUM, VASCULAR; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FIBROBLASTS; HUMANS; KELOID; MALE; MICE; MICE, SCID; NEOVASCULARIZATION, PATHOLOGIC; RNA, MESSENGER; TRANSFORMING GROWTH FACTOR BETA; UP-REGULATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 27544461615     PISSN: 03403696     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00403-005-0596-2     Document Type: Article

References (43)

1. Appleton I, Brown NJ, Willoughby DA (1996) Apoptosis, necrosis, and proliferation: possible implications in the etiology of keloids. Am J Pathol 149:1441-1447
2. Ashcroft GS, Dodsworth J, van Boxtel E, Tarnuzzer RW, Horan MA, Schultz GS, Ferguson MW (1997) Estrogen accelerates cutaneous wound healing associated with an increase in TGF-β1 levels. Nat Med 3:1209-1215
3. Beer TW, Baldwin HC, Goddard JR, Gallagher PJ, Wright DH (1998) Angiogenesis in pathological and surgical scars. Hum Pathol 29:1273-1278
4. Berse B, Hunt JA, Diegel RJ, Morganelli P, Yeo K, Brown F, Fava RA (1999) Hypoxia augments cytokine (transforming growth factor-beta (TGF-β) and IL-1)-induced vascular endothelial growth factor secretion by human synovial fibroblasts. Clin Exp Immunol 115:176-182
5. Bettinger DA, Yager DR, Diegelmann RF, Cohen IK (1996) The effect of TGF-β on keloid fibroblast proliferation and collagen synthesis. Plast Reconstr Surg 98:827-833
6. Brogi E, Wu T, Namiki A, Isner JM (1994) Indirect angiogenic cytokines upregulate VEGF and bFGF gene expression in vascular smooth muscle cells, whereas hypoxia upregulates VEGF expression only. Circulation 90:649-652
7. Chua CC, Hamdy RC, Chua BH (2000) Mechanism of transforming growth factor-β1-induced expression of vascular endothelial growth factor in murine osteoblastic MC3T3-E1 cells. Biochim Biophys Acta 1497:69-76
8. Ehrlich HP, Desmouliere A, Diegelmann RF, Cohen IK, Compton CC, Garner WL, Kapanci Y, Gabbiani G (1994) Morphological and immunochemical differences between keloid and hypertrophic scar. Am J Pathol 145:105-113
9. English RS, Shenefelt PD (1999) Keloids and hypertrophic scars. Dermatol Surg 25:631-638
10. Estrem SA, Domayer M, Bardach J, Cram AE (1987) Implantation of human keloid into athymic mice. Laryngoscope 97:1214-1218
11. Fajardo LF, Prionas SD, Kwan HH, Kowalski J, Allison AC (1996) Transforming growth factor β1 induces angiogenesis in vivo with a threshold pattern. Lab Invest 74:600-608
12. Ferrara N, Gerber HP, LeCouter J (2003) The biology of VEGF and its receptors. Nat Med 9:669-676
13. Gajdusek CM, Luo Z, Mayberg MR (1993) Basic fibroblast growth factor and transforming growth factor beta-1: synergistic mediators of angiogenesis in vitro. J Cell Physiol 157:133-144
14. Gira AK, Brown LF, Washington CV, Cohen C, Arbiser JL (2004) Keloids demonstrate high-level epidermal expression of vascular endothelial growth factor. J Am Acad Dermatol 50:850-853
15. Goumans MJ, Valdimarsdottir G, Itoh S, Rosendahl A, Sideras P, ten Dijke P (2002) Balancing the activation state of the endothelium via two distinct TGF-β type I receptors. EMBO J 21:1743-1753
16. Hicklin DJ, Ellis LM (2005) Role of the vascular endothelial growth factor pathway in tumor growth and angiogenesis. J Clin Oncol 23:1011-1027
17. Hoeben A, Landuyt B, Highley MS, Wildiers H, Van Oosterom AT, De Bruijn EA (2004) Vascular endothelial growth factor and angiogenesis. Pharmacol Rev 56:549-580
18. Jain RK (2003) Molecular regulation of vessel maturation. Nat Med 9:685-693
19. Kischer CW, Thies AC, Chvapil M (1982) Perivascular myofibroblasts and microvascular occlusion in hypertrophic scars and keloids. Hum Pathol 13:819-824
20. Kischer CW, Pindur J, Shetlar MR, Shetlar CL (1989) Implants of hypertrophic scars and keloids into the nude (athymic) mouse: viability and morphology. J Trauma 29:672-677
21. Kischer CW (1992) The microvessels in hypertrophic scars, keloids and related lesions: a review. J Submicrosc Cytol Pathol 24:281-296
22. Le AD, Zhang Q, Wu Y, Messadi DV, Akhondzadeh A, Nguyen AL, Aghaloo TL, Kelly AP, Bertolami CN (2004) Elevated vascular endothelial growth factor in keloids: relevance to tissue fibrosis. Cells Tissues Organs 176:87-94
23. Lee TY, Chin GS, Kim WJ, Chau D, Gittes GK, Longaker MT (1999) Expression of transforming growth factor beta 1, 2, and 3 proteins in keloids. Ann Plast Surg 43:179-184
24. Miyata M, Biro S, Kaieda H, Eto H, Orihara K, Kihara T, Obata H, Matsushita N, Matsuyama T, Tei C (2001) Apolipoprotein J/clusterin is induced in vascular smooth muscle cells after vascular injury. Circulation 104:1407-1412
25. Niessen FB, Spauwen PH, Schalkwijk J, Kon M (1999) On the nature of hypertrophic scars and keloids: a review. Plast Reconstr Surg 104:1435-1458
26. Pepper MS, Vassalli JD, Orci L, Montesano R (1993) Biphasic effect of transforming growth factor-β1 on in vitro angiogenesis. Exp Cell Res 204:356-363
27. Peltonen J, Hsiao LL, Jaakkola S, Sollberg S, Aumailley M, Timpl R, Chu ML, Uitto J (1991) Activation of collagen gene expression in keloids: co-localization of type I and VI collagen and transforming growth factor-β1 mRNA. J Invest Dermatol 97:240-248
28. Pertovaara L, Kaipainen A, Mustonen T, Orpana A, Ferrara N, Saksela O, Alitalo K (1994) Vascular endothelial growth factor is induced in response to transforming growth factor-β in fibroblastic and epithelial cells. J Biol Chem 269:6271-6274
29. Polo M, Kim YJ, Kucukcelebi A, Hayward PG, Ko F, Robson MC (1998) An in vivo model of human proliferative scar. J Surg Res 74:187-195
30. Rahban SR, Garner WL (2003) Fibroproliferative scars. Clin Plast Surg 30:77-89
31. Renner U, Lohrer P, Schaaf L, Feirer M, Schmitt K, Onofri C, Arzt E, Stalla GK (2002) Transforming growth factor-β stimulates vascular endothelial growth factor production by folliculostellate pituitary cells. Endocrinology 143:3759-3765
32. Roberts AB, Sporn MB, Assoian RK, Smith JM, Roche NS, Wakefield LM, Heine UI, Liotta LA, Falanga V, Kehrl JH, Fauci AS (1986) Transforming growth factor type β: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci USA 83:4167-4171
33. Saadeh PB, Mehrara BJ, Steinbrech DS, Dudziak ME, Greenwald JA, Luchs JS, Spector JA, Ueno H, Gittes GK, Longaker MT (1999) Transforming growth factor-β1 modulates the expression of vascular endothelial growth factor by osteoblasts. Am J Physiol 277:C628-C637
34. Schierle HP, Scholz D, Lemperle G (1997) Elevated levels of testosterone receptors in keloid tissue: an experimental investigation. Plast Reconstr Surg 100:390-395
35. Steinbrech DS, Mehrara BJ, Chau D, Rowe NM, Chin G, Lee T, Saadeh PB, Gittes GK, Longaker MT (1999) Hypoxia upregulates VEGF production in keloid fibroblasts. Ann Plast Surg 42:514-519
36. Tuan TL, Nichter LS (1998) The molecular basis of keloid and hypertrophic scar formation. Mol Med Today 4:19-24
37. Vladutiu AO (1993) The severe combined immunodeficient (SCID) mouse as a model for the study of autoimmune diseases. Clin Exp Immunol 93:1-8
38. Wahid S, Blades MC, De Lord D, Brown I, Blake G, Yanni G, Haskard DO, Panayi GS, Pitzalis C (2000) Tumour necrosis factor-alpha (TNF-α) enhances lymphocyte migration into rheumatoid synovial tissue transplanted into severe combined immunodeficient (SCID) mice. Clin Exp Immunol 122:133-142
39. 2 modulates collagen I and collagen III synthesis in proliferative scar xenografts in nude rats. J Surg Res 87:194-200
40. Wu Y, Zhang Q, Ann DK, Akhondzadeh A, Duong HS, Messadi DV, Le AD (2003) Increased vascular endothelial growth factor may account for an elevated level of plasminogen activator inhibitor-1 via activating ERK1/2 in keloid fibroblasts. Am J Physiol Cell Physiol 286:905-912
41. Xia W, Phan TT, Lim IJ, Longaker MT, Yang GP (2004) Complex epithelial-mesenchymal interactions modulate transforming growth factor-β expression in keloid-derived cells. Wound Repair Regen 12:546-556
42. Yoshimoto H, Ishihara H, Ohtsuru A, Akino K, Murakami R, Kuroda H, Namba H, Ito M, Fujii T, Yamashita S (1999) Overexpression of insulin-like growth factor-1 (IGF-I) receptor and the invasiveness of cultured keloid fibroblasts. Am J Pathol 154:883-889
43. Zhang Q, Wu Y, Ann DK, Messadi DV, Tuan TL, Kelly AP, Bertolami CN, Le AD (2003) Mechanisms of hypoxic regulation of plasminogen activator inhibitor-1 gene expression in keloid fibroblasts. J Invest Dermatol 121:1005-1012